Scienture Holdings, Inc. (NASDAQ:SCNX) Sees Significant Decrease in Short Interest

Scienture Holdings, Inc. (NASDAQ:SCNX) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,223,915 shares, a drop of 25.7% from the March 15th total of 2,993,473 shares. Approximately 7.0% of the company’s shares are sold short. Based on an average daily volume of 1,046,354 shares, the short-interest ratio is presently 2.1 days.

Analyst Ratings Changes

SCNX has been the topic of a number of research analyst reports. Maxim Group initiated coverage on shares of Scienture in a report on Tuesday, February 24th. They set a “buy” rating and a $1.50 price objective on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Scienture in a report on Friday, March 27th. Finally, Wall Street Zen upgraded shares of Scienture to a “hold” rating in a report on Saturday, March 14th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $1.50.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Scienture stock. Geode Capital Management LLC grew its position in Scienture Holdings, Inc. (NASDAQ:SCNX) by 264.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 316,201 shares of the company’s stock after acquiring an additional 229,398 shares during the period. Geode Capital Management LLC owned about 0.78% of Scienture worth $161,000 at the end of the most recent quarter. 5.68% of the stock is currently owned by hedge funds and other institutional investors.

Scienture Stock Down 0.8%

Shares of NASDAQ:SCNX traded down $0.00 during midday trading on Thursday, reaching $0.39. 381,617 shares of the company were exchanged, compared to its average volume of 2,961,676. Scienture has a fifty-two week low of $0.24 and a fifty-two week high of $2.60. The stock has a fifty day simple moving average of $0.41 and a two-hundred day simple moving average of $0.56. The firm has a market cap of $15.85 million, a PE ratio of -0.14 and a beta of 3.15.

Scienture (NASDAQ:SCNX) last issued its quarterly earnings data on Monday, March 30th. The company reported ($1.76) EPS for the quarter, missing analysts’ consensus estimates of ($0.28) by ($1.48). The company had revenue of ($0.17) million for the quarter, compared to analyst estimates of $0.49 million.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.